Hinge Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $587.9M | $390.4M | $292.7M | — |
| Cost of revenue | $119.6M | $90.5M | $98.6M | — |
| Gross profit | $468.2M | $299.9M | $194.2M | — |
| Research and development | $368.1M | $100.8M | $110.1M | — |
| Operating expenses | $1.0B | $331.8M | $324.7M | — |
| Operating income | -$546.4M | -$31.9M | -$130.5M | — |
| Pretax income | -$527.3M | -$11.3M | -$108.5M | — |
| Income tax expense | $998,000 | $677,000 | -$405,000 | — |
| Net income | -$528.3M | -$11.9M | -$108.1M | — |
| Balance Sheet | ||||
| Cash and equivalents | $208.0M | $300.8M | $235.0M | — |
| Current assets | $533.9M | $583.4M | — | — |
| Total assets | $744.8M | $673.3M | — | — |
| Current liabilities | $362.4M | $249.3M | — | — |
| Total liabilities | $366.2M | $256.6M | — | — |
| Stockholders' equity | $178.7M | -$434.6M | -$424.0M | -$318.1M |
| Cash Flow Statement | ||||
| Cash from operations | $171.4M | $49.0M | -$63.9M | — |
| Depreciation and amortization | $1.3M | $2.0M | $1.8M | — |
| Stock-based compensation | $643.0M | $739,000 | $1.6M | — |
| Capital expenditure | $708,000 | $1.0M | $2.0M | — |
| Free cash flow | $170.7M | $48.0M | -$65.9M | — |
| Share repurchases | $65.0M | $0 | $0 | — |
| Impairments | $0 | $0 | $0 | — |
Shares outstanding 77.4M · Free float 54.6%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.